Rejane Mattar

Rejane Mattar

Auto-generated profile, based on publicly available information

Rejane Mattar

Universidade de São Paulo, Brasil

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012 in Clinical and Experimental Gastroenterology
Verified
Journal Article
Open access
PDF file
RMRejane Mattar
Rejane Mattar
DMDaniel Ferraz De Campos Mazo
Daniel Ferraz De Campos Mazo
FCFlair José Carrilho
Flair José Carrilho
DMDaniel Ferraz de Campos Mazo
Daniel Ferraz de Campos Mazo
Most people are born with the ability to digest lactose, the major carbohydrate in milk and the main source of nutrition until weaning. Approximately 75% of the world's population loses this ability at some point, while others can digest lactose into adulthood. This review discusses the lactase-persistence alleles that have arisen in different populations around the world, diagnosis of lactose intolerance, and its symptomatology and management.

14 June 2007 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
RIRobson K. Ishida
Robson K. Ishida
JFJoel Faintuch
Joel Faintuch
APAna M. R. Paula
Ana M. R. Paula
CRChristiane A. Risttori
Christiane A. Risttori
SSSabrina N. Silva
Sabrina N. Silva
ICIvan Cecconello
Ivan Cecconello

26 March 2013 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
TNTomás Navarro-Rodriguez
Tomás Navarro-Rodriguez
FSFernando Marcuz Silva
Fernando Marcuz Silva
RBRicardo Correa Barbuti
Ricardo Correa Barbuti
RMRejane Mattar
Rejane Mattar
JMJoaquim Prado Moraes-Filho
Joaquim Prado Moraes-Filho
JEJaime Natan Eisig
Jaime Natan Eisig
The treatment for the eradication of Helicobacter pylori (H. pylori) is complex; full effectiveness is rarely achieved and it has many adverse effects. In developing countries, increased resistance to antibiotics and its cost make eradication more difficult. Probiotics can reduce adverse effects and improve the infection treatment efficacy.

1 June 2002 in Revista Do Hospital Das Clinicas
Verified
Journal Article
Open access
PDF file
RMRejane Mattar
Rejane Mattar
CAClaudio Roberto Alves de Andrade
Claudio Roberto Alves de Andrade
GDGiovanni Mastrantonio DiFavero
Giovanni Mastrantonio DiFavero
JGJoaquim José Gama-Rodrigues
Joaquim José Gama-Rodrigues
ALAntonio Atílio Laudanna
Antonio Atílio Laudanna
INTRODUCTION: The clinical importance of preoperative serum levels of CA 72-4, carcinoembryonic antigen (CEA), CA 19-9, and alpha-fetoprotein (AFP) was prospectively evaluated in 44 patients with gastric cancer. METHOD: The serum tumor marker levels were determined by commercial radioimmunoassay kits. Positivity for CA 72-4 (>4 U/mL), CEA (>5 ng/mL), CA 19-9 (>37 U/mL), and AFP (>10 ng/mL) were correlated according to the stage, histology, and lymph node metastasis. RESULTS AND DISCUSSION: CA 72-4 showed a higher positivity rate for gastric cancer (47.7%) than CEA (25%), CA 19-9 (25%), and AFP (0%). The combination of CA 72-4 with CEA and CA 19-9 increased the sensitivity to 61.4%. The positivity rates of CA 72-4 in patients at stages I and II (initial disease) and in patients at stages III and IV (advanced disease) were 9% and 60.6%, respectively (P < 0.005). No correlation was found between CEA and CA 19-9 levels and the stage of gastric cancer. There was a tendency of positivity for CA 72-4 to suggest lymph node involvement, but it was not significant (P = 0.075). Serum levels of tumor markers did not show a correlation with the histological types of gastric cancer. CONCLUSION: Preoperative serum levels of CA 72-4 provided a predictive value in indicating advanced gastric cancer.

1 January 2007 in Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
RMRejane Mattar
Rejane Mattar
SMSergio Barbosa Marques
Sergio Barbosa Marques
MMMaria Do Socorro Monteiro
Maria Do Socorro Monteiro
ASAnibal Ferreira dos Santos
Anibal Ferreira dos Santos
KIKiyoshi Iriya
Kiyoshi Iriya
FCFlair José Carrilho
Flair José Carrilho
The purpose of this study was to verify whether the presence of any of the Helicobacter pylori cagPAI genes or segments – cagA, cagA promoter, cagE, cagM, tnpB, tnpA, cagT and the left end of the cag II (LEC) region – would be a useful marker for the risk of peptic ulcer disease development. H. pylori DNA extracted from positive urease tests of 150 peptic ulcer patients and 65 dyspeptic controls was analysed by PCR. Duodenal ulcers were present in 110, gastric ulcers in 23 and both gastric and duodenal ulcers in 17 patients. A significant association (P <0.001) was found between a conserved cagPAI and peptic ulcer disease (34 %). The positivity of the cagA gene varied according to the region of the gene that was amplified. The region near to the promoter was present in almost all of the H. pylori isolates (97.2 %). The segment from nt 1764 to 2083 and the extreme right end were frequently deleted in the isolates from the controls (P <0.01). The positivity of the promoter region of cagA and cagT, cagE, cagM and LEC showed a significant difference between the isolates from peptic ulcer patients and from the controls (P <0.01). Patients usually had moderate gastritis; however, the intensity of the active inflammation was higher in the peptic ulcer group (P <0.001). cagT, cagM, LEC and the right end terminus of the cagA-positive H. pylori isolates were associated with a 27-fold, 8-fold, 4-fold and 4-fold risk of peptic ulcer disease, respectively, and may be useful markers to identify individuals at higher risk of peptic ulcer disease development in Brazil.

7 November 2005 in Helicobacter
Verified
Journal Article
Closed access
PDF file
RMRejane Mattar
Rejane Mattar
ASAnibal Ferreira dos Santos
Anibal Ferreira dos Santos
JEJaime Natan Eisig
Jaime Natan Eisig
TRTomas Navarro Rodrigues
Tomas Navarro Rodrigues
FSFernando Marcuz Silva
Fernando Marcuz Silva
FCFlair José Carrilho
Flair José Carrilho